These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34268573)

  • 1. Primary care provider perspectives on and utilization of a mandatory prescription drug monitoring program in New York City.
    Harocopos A; Allen B; Chernick R
    Fam Pract; 2022 Mar; 39(2):264-268. PubMed ID: 34268573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City.
    Chernick R; Allen B; Harocopos A
    J Behav Health Serv Res; 2022 Apr; 49(2):122-133. PubMed ID: 34426933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.
    Radomski TR; Bixler FR; Zickmund SL; Roman KM; Thorpe CT; Hale JA; Sileanu FE; Hausmann LRM; Thorpe JM; Suda KJ; Stroupe KT; Gordon AJ; Good CB; Fine MJ; Gellad WF
    J Gen Intern Med; 2018 Aug; 33(8):1253-1259. PubMed ID: 29520747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
    Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
    Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.
    Stucke RS; Kelly JL; Mathis KA; Hill MV; Barth RJ
    JAMA Surg; 2018 Dec; 153(12):1105-1110. PubMed ID: 30140927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug monitoring program design and function: A qualitative analysis.
    Rutkow L; Smith KC; Lai AY; Vernick JS; Davis CS; Alexander GC
    Drug Alcohol Depend; 2017 Nov; 180():395-400. PubMed ID: 28978492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in prescription drug monitoring program use by prescriber specialty.
    Sun BC; Lupulescu-Mann N; Charlesworth CJ; Kim H; Hartung DM; Deyo RA; John McConnell K
    J Subst Abuse Treat; 2018 Nov; 94():35-40. PubMed ID: 30243415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
    Martello J; Cassidy B; Mitchell A
    J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact evaluation of a brief online training module on physician use of the Maryland, USA, Prescription Drug Monitoring Program.
    Adenaiye OO; Zirpoli JB; Tan M; Day BF; Bolaji O; Mitchell CS; Cloeren M
    PLoS One; 2022; 17(8):e0272217. PubMed ID: 35944051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cycles of Chronic Opioid Therapy Following Mandatory Prescription Drug Monitoring Program Legislation: A Retrospective Cohort Study.
    Allen B; Jent VA; Cerdá M
    J Gen Intern Med; 2022 Dec; 37(16):4088-4094. PubMed ID: 35411535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance Use Stigma, Primary Care, and the New York State Prescription Drug Monitoring Program.
    Allen B; Harocopos A; Chernick R
    Behav Med; 2020; 46(1):52-62. PubMed ID: 30726167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Florida's Prescription Drug Monitoring Program registration and utilization: Implications for increasing voluntary use.
    Delcher C; Wang Y; Young HW; Goldberger BA; Schmidt S; Reisfield GM
    J Opioid Manag; 2017; 13(5):283-289. PubMed ID: 29199394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survey of Physicians' Perspectives on the New York State Mandatory Prescription Monitoring Program (ISTOP).
    Blum CJ; Nelson LS; Hoffman RS
    J Subst Abuse Treat; 2016 Nov; 70():35-43. PubMed ID: 27692186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of prescription drug monitoring programs for prescribing and dispensing decisions: Results from a multi-site qualitative study.
    Freeman PR; Curran GM; Drummond KL; Martin BC; Teeter BS; Bradley K; Schoenberg N; Edlund MJ
    Res Social Adm Pharm; 2019 Jun; 15(6):754-760. PubMed ID: 30243575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
    Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
    Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.
    Bachhuber MA; Tuazon E; Nolan ML; Kunins HV; Paone D
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):734-739. PubMed ID: 30920062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstetrician-gynecologist perceptions and utilization of prescription drug monitoring programs: A survey study.
    Goodin A; Bae J; Delcher C; Brown J; Roussos-Ross D
    Medicine (Baltimore); 2021 Jan; 100(1):e24268. PubMed ID: 33429837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.